Related references
Note: Only part of the references are listed.Aerosolized Rift Valley Fever Virus Causes Fatal Encephalitis in African Green Monkeys and Common Marmosets
Amy L. Hartman et al.
JOURNAL OF VIROLOGY (2014)
Antiviral Efficacy of Favipiravir against Two Prominent Etiological Agents of Hantavirus Pulmonary Syndrome
David Safronetz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Post-exposure Vaccination with MP-12 lacking NSs protects mice against lethal Rift Valley fever virus challenge
Brian B. Gowen et al.
ANTIVIRAL RESEARCH (2013)
Influenza virus resistance to neuraminidase inhibitors
Melanie Samson et al.
ANTIVIRAL RESEARCH (2013)
Neuraminidase inhibitors for influenza B virus infection: Efficacy and resistance
Andrew J. Burnham et al.
ANTIVIRAL RESEARCH (2013)
Relevance of Rift Valley fever to public health in the European Union
V. Chevalier
CLINICAL MICROBIOLOGY AND INFECTION (2013)
Potential for Mosquitoes (Diptera: Culicidae) From Florida to Transmit Rift Valley Fever Virus
Michael J. Turell et al.
JOURNAL OF MEDICAL ENTOMOLOGY (2013)
Intervention strategies for emerging viruses: use of antivirals
Yannick Debing et al.
CURRENT OPINION IN VIROLOGY (2013)
Aerosol Exposure to Rift Valley Fever Virus Causes Earlier and More Severe Neuropathology in the Murine Model, which Has Important Implications for Therapeutic Development
Christopher Reed et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
The transmission potential of Rift Valley fever virus among livestock in the Netherlands: a modelling study
Egil A. J. Fischer et al.
VETERINARY RESEARCH (2013)
A temperature-limited assessment of the risk of Rift Valley fever transmission and establishment in the continental United States of America
Sarah K. Konrad et al.
GEOSPATIAL HEALTH (2012)
Choice of inbred rat strain impacts lethality and disease course after respiratory infection with Rift Valley Fever Virus
Jacquelyn M. Bales et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2012)
T-705 (Favipiravir) Inhibition of Arenavirus Replication in Cell Culture
Michelle Mendenhall et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
POTENTIAL FOR CANADIAN MOSQUITOES TO TRANSMIT RIFT VALLEY FEVER VIRUS
M. Iranpour et al.
JOURNAL OF THE AMERICAN MOSQUITO CONTROL ASSOCIATION (2011)
The Status of Rift Valley Fever in Animals in Saudi Arabia: A Mini Review
Adel I. Al-Afaleq et al.
VECTOR-BORNE AND ZOONOTIC DISEASES (2011)
Effective Oral Favipiravir (T-705) Therapy Initiated after the Onset of Clinical Disease in a Model of Arenavirus Hemorrhagic Fever
Michelle Mendenhall et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
Levofloxacin Cures Experimental Pneumonic Plague in African Green Monkeys
Robert Colby Layton et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
An Assessment of the Regional and National Socio-Economic Impacts of the 2007 Rift Valley Fever Outbreak in Kenya
Karl M. Rich et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2010)
Efficacy of favipiravir (T-705) and T-1106 pyrazine derivatives in phlebovirus disease models
Brian B. Gowen et al.
ANTIVIRAL RESEARCH (2010)
T-705 (favipiravir) activity against lethal H5N1 influenza A viruses
Maki Kiso et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The pathogenesis of Rift Valley fever virus in the mouse model
Darci R. Smith et al.
VIROLOGY (2010)
Activity of T-705 in a Hamster Model of Yellow Fever Virus Infection in Comparison with That of a Chemically Related Compound, T-1106
Justin G. Julander et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Effect of T-705 treatment on western equine encephalitis in a mouse model
Justin G. Julander et al.
ANTIVIRAL RESEARCH (2009)
T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections
Yousuke Furuta et al.
ANTIVIRAL RESEARCH (2009)
Efficacy of orally administered T-705 pyrazine analog on lethal West Nile virus infection in rodents
John D. Morrey et al.
ANTIVIRAL RESEARCH (2008)
Treatment of Late Stage Disease in a Model of Arenaviral Hemorrhagic Fever: T-705 Efficacy and Reduced Toxicity Suggests an Alternative to Ribavirin
Brian B. Gowen et al.
PLOS ONE (2008)
In vitro and in vivo activities of T-705 against arenavirus and bunyavirus infections
Brian B. Gowen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Rift Valley fever virus lacking NSm proteins retains high virulence in vivo and may provide a model of human delayed onset neurologic disease
Brian H. Bird et al.
VIROLOGY (2007)
Mechanism of action of T-705 against influenza virus
Y Furuta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Hemorrhagic fever viruses as biological weapons - Medical and public health management
L Borio et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Share Paper
